Thus, GSDMB amplification was detected in 21 tumours, and 15 of them (71.4%) were HER2-positive cases, therefore confirming the association between the both amplifications (p = 0.034, Table 1, Figure 2A, panel d). Here, GSDMB is linked to neoplasm.